OOIR: Observatory of International Research

Papers

(The H4-Index of AIDS is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
The need to avert emergent resistance to dolutegravir in children and adolescents with HIV	56
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy	55
Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa	50
Strategies for managing weight gain associated with antiretroviral therapy: switch or add?	46
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery	46
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine	46
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV	35
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief	34
A new frontier in HIV care: the predictive power of renal biomarkers on heart health	34
Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection	33
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure – two nationwide, population-based cohort studies	33
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV	32
Real world use of dolutegravir two drug regimens	29
Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum	28
Cerebral toxoplasmosis in the twenty-first century	28
Reduced bone density accrual among peripubertal boys with HIV in Zimbabwe: Erratum	27
Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention research	26
Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men	26
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin	26
Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France	26
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease	25
HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood–retinal barrier	25
Trends in population HIV viral suppression: a longitudinal analysis	24
Applying rigorous real-world evidence methodology in HIV medicine: is more evidence needed with long-acting cabotegravir/rilpivirine?	23